NPX levels of HGF, CSF3, MMP1, oncostatin M (OSM), IL-6 and vascular endothelial growth factor A (VEGFA) were elevated in CH patients as compared to controls (Fig. 4). This evidence concerns the gene IL6 and cyclic hematopoiesis.